Fractional CFO vs Controller for a Specialty Clinic Group

A client who pays for a six-session package or a monthly membership hasn't received six sessions or a month of value yet on day one. That revenue should be recognized as sessions are delivered or as the membership period elapses, not booked in full at the point of sale. Businesses that book it all upfront look artificially strong in months with heavy package sales and artificially weak once that sales pace slows, which makes it hard to judge whether the clinic is actually growing.

Injectables and many devices carry real per-unit cost and finite shelf life, and treating this inventory the way a retail business treats shelf-stable goods misses both waste from expired product and the true cost of goods behind each treatment. A controller should track inventory by lot and expiration where the product requires it, and reconcile actual usage against what was billed for, since a gap between the two is either theft, waste, or a documentation problem worth finding.

Many clinics pay providers, injectors, estheticians, and physicians, some combination of base pay, commission on services performed, and bonus tied to retail product sales. Each of these needs to be tracked and accrued separately against the revenue it's tied to, or the clinic can't tell whether a given provider's schedule is actually profitable once true compensation cost is counted against the revenue they generated.

• Insurance-billed visits have a collection cycle and write-off pattern that cash-pay and package revenue don't
• Blending the two hides whether growth is coming from higher-margin cash-pay services or lower-margin insurance visits
• Insurance write-offs need to be tracked by payer, the same as any medical practice, not absorbed into a general expense line
• Cash-pay pricing decisions need clean cash-pay margin data, which isn't visible if insurance and cash-pay revenue are combined

A clinic growing its cash-pay or membership business specifically needs this split to know whether that strategy is actually working.

With package revenue recognized correctly, inventory reconciled by unit, provider comp accrued accurately, and insurance separated from cash-pay, a fractional CFO's core work becomes service-mix strategy: which treatments or membership tiers to promote more heavily based on true margin, not just top-line revenue per visit. Financing a new device purchase or a second location build-out also enters this conversation, and since that financing typically prices off the bank prime rate, current borrowing costs should be part of the return calculation rather than an assumption carried over from a prior year¹.

Ask a candidate how they'd handle a client who purchases a six-session package, uses two sessions this month, and the remaining four next quarter, with a portion of the package price allocated to a retail product bundled in. A candidate with real medical spa or wellness clinic experience will describe splitting the bundle into its service and product components and recognizing each on its own schedule; someone without that background will often just book the full amount as revenue at the point of sale, missing both the deferral and the bundling issue entirely.

Many aesthetic and wellness services see real seasonal demand swings, heavier before major holidays or summer, for example, which means provider scheduling and cash flow both need to account for that pattern rather than assuming flat demand year round. A fractional CFO should be building a rolling cash plan that reflects the clinic's actual seasonal pattern, informed by at least a full year of clean historical data, rather than a generic monthly average that smooths over swings the business actually experiences.

A new device purchase is often financed rather than paid outright, and the decision to finance versus lease versus pay cash should weigh utilization projections against the financing terms available, not just whichever option has the lowest monthly payment. A controller can supply accurate utilization and margin-per-treatment data; the actual financing decision, and how it fits the clinic's broader capital plan, belongs with a fractional CFO who's looking at the whole picture rather than one purchase in isolation.